ONCODESIGN
Developing precision oncology solutions for resistant and metastatic cancers.
ALONC | PA
Overview
Corporate Details
- ISIN(s):
- FR0011766229
- LEI:
- 9695004HPDBVG72O8851
- Country:
- France
- Address:
- 20 RUE JEAN MAZEN, 21000 DIJON
- Website:
- https://www.oncodesign.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Oncodesign Precision Medicine (OPM) is a biotechnology company dedicated to developing innovative therapeutic and diagnostic solutions. The company's core mission is to address therapeutic resistance and metastasis in cancer through a precision medicine approach. Utilizing a patient-centric, translational model, OPM focuses on discovering and advancing treatments for patients with resistant and metastatic cancers. The company collaborates with clinicians, service providers, and experts to guide its research and development investments towards meeting significant unmet medical needs in oncology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-12-13 14:25 |
Delisting Announcement
Communiqués publiés en période d'offre publique d'acquisition / OPA Autres comm…
|
French | 150.7 KB | ||
| 2022-12-13 11:17 |
Major Shareholding Notification
Franchissement de seuils
|
French | 209.0 KB | ||
| 2022-11-24 08:00 |
M&A Activity
Communiqués publiés en période d'offre publique d'acquisition / OPA Modalités d…
|
French | 145.1 KB | ||
| 2022-11-23 17:37 |
Prospectus
Communiqués publiés en période d'offre publique d'acquisition / OPA Modalités d…
|
French | 724.9 KB | ||
| 2022-11-23 17:36 |
M&A Activity
Communiqués publiés en période d'offre publique d'acquisition / OPA Modalités d…
|
French | 2.3 MB | ||
| 2022-11-08 16:38 |
M&A Activity
Communiqués publiés en période d'offre publique d'acquisition / OPA Modalités d…
|
French | 2.2 MB | ||
| 2022-11-08 15:54 |
Delisting Announcement
Communiqués publiés en période d'offre publique d'acquisition / OPA Modalités d…
|
French | 231.6 KB | ||
| 2022-11-02 17:28 |
Prospectus
Communiqués publiés en période d'offre publique d'acquisition / OPA Modalités d…
|
French | 1.0 MB | ||
| 2022-11-02 17:25 |
Prospectus
Communiqués publiés en période d'offre publique d'acquisition / OPA Modalités d…
|
French | 506.0 KB | ||
| 2022-10-26 11:17 |
Major Shareholding Notification
Franchissement de seuil
|
French | 198.3 KB | ||
| 2022-10-26 11:16 |
Major Shareholding Notification
Franchissement de seuils
|
French | 206.0 KB | ||
| 2022-10-19 08:00 |
M&A Activity
Inside Information / Operations of the issuer (acquisitions, sales...)
|
English | 340.5 KB | ||
| 2022-10-19 08:00 |
M&A Activity
Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
|
French | 390.8 KB | ||
| 2022-10-04 18:00 |
Delisting Announcement
Inside Information / Other news releases
|
English | 268.6 KB | ||
| 2022-10-04 18:00 |
Delisting Announcement
Informations privilégiées / Autres communiqués
|
French | 273.9 KB |
Automate Your Workflow. Get a real-time feed of all ONCODESIGN filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ONCODESIGN
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ONCODESIGN via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
